216 related articles for article (PubMed ID: 20585454)
1. The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Côte d'Ivoire.
Beaulière A; Touré S; Alexandre PK; Koné K; Pouhé A; Kouadio B; Journy N; Son J; Ettiègne-Traoré V; Dabis F; Eholié S; Anglaret X
PLoS One; 2010 Jun; 5(6):e11213. PubMed ID: 20585454
[TBL] [Abstract][Full Text] [Related]
2. Evidence of High Out of Pocket Spending for HIV Care Leading to Catastrophic Expenditure for Affected Patients in Lao People's Democratic Republic.
Barennes H; Frichittavong A; Gripenberg M; Koffi P
PLoS One; 2015; 10(9):e0136664. PubMed ID: 26327558
[TBL] [Abstract][Full Text] [Related]
3. Socio-economic and health characteristics of HIV-infected patients seeking care in relation to access to the Drug Access Initiative and to antiretroviral treatment in Côte d'Ivoire.
Msellati P; Juillet-Amari A; Prudhomme J; Akribi HA; Coulibaly-Traore D; Souville M; Moatti JP;
AIDS; 2003 Jul; 17 Suppl 3():S63-8. PubMed ID: 14565611
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA
PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009
[TBL] [Abstract][Full Text] [Related]
5. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
[TBL] [Abstract][Full Text] [Related]
6. Access to antiretroviral treatment and sexual behaviours of HIV-infected patients aware of their serostatus in Côte d'Ivoire.
Moatti JP; Prudhomme J; Traore DC; Juillet-Amari A; Akribi HA; Msellati P;
AIDS; 2003 Jul; 17 Suppl 3():S69-77. PubMed ID: 14565612
[TBL] [Abstract][Full Text] [Related]
7. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
[TBL] [Abstract][Full Text] [Related]
8. HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Côte d'Ivoire.
Hanson DL; Adjé-Touré C; Talla-Nzussouo N; Eby P; Borget MY; Kouadio LY; Celestin BE; Tossou O; Eholie S; Kadio A; Chorba T; Nkengasong JN
AIDS Res Hum Retroviruses; 2009 May; 25(5):489-95. PubMed ID: 19388820
[TBL] [Abstract][Full Text] [Related]
9. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
[TBL] [Abstract][Full Text] [Related]
10. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.
Djomand G; Roels T; Ellerbrock T; Hanson D; Diomande F; Monga B; Maurice C; Nkengasong J; Konan-Koko R; Kadio A; Wiktor S; Lackritz E; Saba J; Chorba T
AIDS; 2003 Jul; 17 Suppl 3():S5-15. PubMed ID: 14565604
[TBL] [Abstract][Full Text] [Related]
11. Assessment of out-of-pocket and catastrophic expenses incurred by patients with Human Immunodeficiency Virus (HIV) in availing free antiretroviral therapy services in India.
Alvi Y; Faizi N; Khalique N; Ahmad A
Public Health; 2020 Jun; 183():16-22. PubMed ID: 32413804
[TBL] [Abstract][Full Text] [Related]
12. Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008.
Abo Y; Minga A; Menan H; Danel C; Ouassa T; Dohoun L; Bomisso G; Tanoh A; Messou E; Eholié S; Lewden C; Anglaret X
BMC Infect Dis; 2013 Dec; 13():607. PubMed ID: 24373303
[TBL] [Abstract][Full Text] [Related]
13. Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.
McNairy ML; Bashi JB; Chung H; Wemin L; Lorng MA; Brou H; Nioble C; Lokossue A; Abo K; Achi D; Ouattara K; Sess D; Sanogo PA; Ekra A; Ettiegne-Traore V; Diabate CJ; Abrams EJ; El-Sadr WM
Trop Med Int Health; 2017 Apr; 22(4):431-441. PubMed ID: 28101954
[TBL] [Abstract][Full Text] [Related]
14. Willingness to use HIV self-test kits and willingness to pay among urban antenatal clients in Cote d'Ivoire and Tanzania: a cross-sectional study.
Ashburn K; Antelman G; N'Goran MK; Jahanpour O; Yemaneberhan A; N'Guessan Kouakou B; Kazemi E; Duffy M; Adama P; Kajoka D; Coombs A; Tayag J; Sullivan D; Vrazo A
Trop Med Int Health; 2020 Sep; 25(9):1155-1165. PubMed ID: 32609932
[TBL] [Abstract][Full Text] [Related]
15. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
[TBL] [Abstract][Full Text] [Related]
16. Financial burdens of HIV and chronic disease on people living with HIV in Côte d'Ivoire: A cross-sectional out-of-pocket expenditure study.
Stelmach RD; Rabkin M; Abo K; Ahoba I; Gildas Anago M; Boccanera R; Brou H; Flueckiger R; Hartsough K; Msukwa M; Zech J; Young F; Nugent R
PLoS One; 2021; 16(7):e0255074. PubMed ID: 34324545
[TBL] [Abstract][Full Text] [Related]
17. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
[TBL] [Abstract][Full Text] [Related]
18. Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.
Minga A; Lewden C; Dohoun L; Abo Y; Emieme A; Coulibaly A; Salamon R; Eholié S; Anglaret X; Danel C;
AIDS Res Hum Retroviruses; 2010 Sep; 26(9):991-5. PubMed ID: 20707728
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire.
Coffie PA; Tonwe-Gold B; Tanon AK; Amani-Bosse C; Bédikou G; Abrams EJ; Dabis F; Ekouevi DK
BMC Infect Dis; 2010 Jun; 10():188. PubMed ID: 20576111
[TBL] [Abstract][Full Text] [Related]
20. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire.
Ghehi C; Gabillard D; Moh R; Badje A; Kouamé GM; Oouttara E; Ahibo H; N'Takpé JB; Lecarrou J; Eholié SP; Anglaret X; Danel C
PLoS One; 2017; 12(6):e0177440. PubMed ID: 28582393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
